Zhejiang Tianyu Pharmaceutical Co. Ltd. – FDA 483, Apr 12, 2019
An FDA inspection of Zhejiang Tianyu Pharmaceutical Co Ltd, an Active Pharmaceutical Ingredient (API) manufacturer, revealed significant deficiencies across its quality systems, facilities, and production processes. The firm failed to conduct adequate investigations into product contamination and customer complaints, lacked proper quality agreements with contract laboratories, and exhibited critical shortcomings in cleaning and process validation. Additionally, the facility's warehouse for API storage was found to be in a poor state of repair.
ID · 12b21610-c7db-4c2e-a2d4-66386a433333
Comes with the profile
KRA (KeyPedia Risk Analysis)
How likely the FDA is to take enforcement action in the next 12 months.
Example18-month trend
Form 483 · April 12, 2019
What you get
A document
One file.
- One FDA document, such as a Form 483
- Yours for life in your Library
- Each has its own price
The profile
All the documents, plus intelligence about the company.
- Every Zhejiang Tianyu Pharmaceutical Co. Ltd. document on file
- The KRA score, which a single document does not include
- Observations and inspection history
Access
This, for every company on KeyPedia.
- Combine profiles in one search
- Search across any modality: products, industry types, drugs, devices and recalls
- Track everything as it changes
- Other agencies too, such as EMA, Health Canada and UK MHRA